4,003
Participants
Start Date
June 18, 2010
Primary Completion Date
November 18, 2011
Study Completion Date
July 17, 2013
GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108)
Three doses of 3 different manufacturing lots in primary study at 2, 4 and 6 months of age as intramuscular injection and one dose as booster vaccination.
ActHIB™
Three doses in primary epoch at 2, 4 and 6 months of age as intramuscular injection and one dose as a booster vaccination
Pentacel™
Three doses in primary epoch at 2, 4 and 6 months of age as intramuscular injection and one dose as a booster vaccination
Pediarix™
Three doses in primary epoch at 2, 4 and 6 months of age as intramuscular injection
Prevnar 13™
Three doses in primary epoch at 2, 4 and 6 months of age as intramuscular injection
Rotarix™
Two oral doses in primary epoch at 2 and 4 months of age
Engerix™-B
Two or three doses in primary epoch at 2,( 4) and 6 months of age as intramuscular injection
Infanrix™
One dose in the booster epoch at 15-18 months of age as intramuscular injection
GSK Investigational Site, Mineola
GSK Investigational Site, Syracuse
GSK Investigational Site, Utica
GSK Investigational Site, Greenville
GSK Investigational Site, Hermitage
GSK Investigational Site, Erie
GSK Investigational Site, Charleston
GSK Investigational Site, Marietta
GSK Investigational Site, Woodstock
GSK Investigational Site, Orange City
GSK Investigational Site, Dothan
GSK Investigational Site, Bardstown
GSK Investigational Site, Louisville
GSK Investigational Site, Cleveland
GSK Investigational Site, Canton
GSK Investigational Site, Cincinnati
GSK Investigational Site, Dayton
GSK Investigational Site, Stevensville
GSK Investigational Site, Madison
GSK Investigational Site, Marshfield
GSK Investigational Site, Saint Paul
GSK Investigational Site, Fargo
GSK Investigational Site, Omaha
GSK Investigational Site, Benton
GSK Investigational Site, Little Rock
GSK Investigational Site, Jonesboro
GSK Investigational Site, Fayetteville
GSK Investigational Site, Tulsa
GSK Investigational Site, Fort Worth
GSK Investigational Site, Houston
GSK Investigational Site, Sugar Land
GSK Investigational Site, Amarillo
GSK Investigational Site, Boulder
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Nampa
GSK Investigational Site, Bountiful
GSK Investigational Site, Layton
GSK Investigational Site, Roy
GSK Investigational Site, Syracuse
GSK Investigational Site, South Jordan
GSK Investigational Site, Salt Lake City
GSK Investigational Site, West Covina
GSK Investigational Site, Huntington Beach
GSK Investigational Site, Fountain Valley
GSK Investigational Site, Anaheim
GSK Investigational Site, Fresno
GSK Investigational Site, Daly City
GSK Investigational Site, Redwood City
GSK Investigational Site, Antioch
GSK Investigational Site, Fremont
GSK Investigational Site, Hayward
GSK Investigational Site, Vallejo
GSK Investigational Site, Walnut Creek
GSK Investigational Site, Oakland
GSK Investigational Site, Santa Clara
GSK Investigational Site, San Jose
GSK Investigational Site, Santa Rosa
GSK Investigational Site, Roseville
GSK Investigational Site, Sacramento
GSK Investigational Site, Sacramento
GSK Investigational Site, Waipio
GSK Investigational Site, Honolulu
GSK Investigational Site, Fall River
Lead Sponsor
GlaxoSmithKline
INDUSTRY